THE USE OF CITICOLINE (CERAXON) IN THE TREATMENT OF BRAIN INJURIES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The choice of neuroprotector citicoline (Ceraxon), reasoned by evidence-based research in stroke and chronic brain ischemia, for the treatment of the consequences of brain injury is presented in the paper. International multicenter studies, comparative meta-analysis of existing results of treatment of patients with traumatic brain injury (TBI) and its consequences with the use of citicoline (Ceraxon) are discussed. The recommended circuit to use the drug at various stages of treatment of victims with traumatic brain trauma is presented.

Full Text

Restricted Access

About the authors

Valery Genrikhovich AMCHESLAVSKY

Children's Clinical and Research Institute of Emergency Surgery and Trauma

Email: vamches@mail.ru
MD, Professor, Head of Anesthesiology and Critical Care Department 119180, Moscow, 22 B. Polyanka St

References

  1. Waxweiler R.J., Thurman D. Sniezek J., Sosin D., O'Neil J. Monitoring the impact of traumatic brain injury: а review and update. J. Neurotrauma. 1995;12(4):509-16.
  2. Corrigan J.D., Selassie A.W., Orman J.A. The epidemiology of traumatic brain injury. J. Head Trauma Rehabil. 2010;25(2):72-80.
  3. Lu J., Marmarou A., Choi S., Maas A., Murray G., Steyerberg E.W.; Impact and Abic Study Group. Mortality from traumatic brain injury. Acta. Neurochir Suppl. 2005;95:281-5.
  4. Овсянников Д.М., Чехонацкий А.А., Колесов В.Н., Бубашвили А.И. Социальные и эпидемиологические аспекты черепно-мозговой травмы (обзор). Саратовский научно-медицинский журнал. 2012;8(3):777-83.
  5. Dawodu S.T., Kishner S. Traumatic brain injury (TBI) - definition and pathophysiology. Meds«pe, 2015.
  6. Âlvarez X.A., Figueroa J., Muresanu D. Peptidergic drugs for the treatment of traumatic brain injury. Future Neurology. 2013;8(2):175-92.
  7. Белова А.Н. Нейрореабилитация. Руководство для врачей. М.: Антидор, 2002. С. 420-502.
  8. Maas A.I., Stocchetti N., Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728-41.
  9. Амчеславский В.Г. Нейропротективная терапия в остром периоде церебральных поражений. Методическое пособие (для специалистов здравоохранения). М., 2009. 29 с.
  10. Secades J.J., Delgadillo J., Oudovenko N. Role of citicoline on the treatment of ischemic stroke: a formal and cumulative meta-analysis. 7th World congress on controversies in neurology. Istanbul, Turkey, 2013.
  11. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М.: Медицина, 2001. 328 с.
  12. Adams H., Adams R., Del Zoppo G., Goldstein L.B. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005;36 (4):916-23
  13. Leker R.R., Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Brain Res. Rev. 2002;39:55-73.
  14. Secades J.J., Lorenzo J.L. Citicoline: pharmacological and clinical review. Methods Find Exp. Clin. Pharmacol. 2006;27(Suppl В):1-56.
  15. El Reweny E.M., Okasha A., Hafez A. The neuroprotective effect of citicholine (CDP choline) in patients with traumatic brain injury, 25th ESICM Annual Congress, Lisbon, Portugal, 2012.
  16. Chida N., Shimizu Y. Biosynthesis of myelin lipids of cultured nervous tissues. Incorporation of choline and CDP-choline into myelin phospholipids. Tohoku J. Exp. Med. 1973;111:41-9.
  17. Weiss G.B. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci. 1995;56:637-60.
  18. Farooqui A.A., Horrocks L.A., Farooqui T. Glycerophospholipids in brain: their metabolism, in corporation to membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids. 2000;106:1-29.
  19. Klein J. Membrane breakdown in acute and chronic neurodegeneration: Focus on choline-containing phospholipids. J. Neural. Transm. 2000;107:1027-63.
  20. Baburina I., Jackowski S. Apoptosis triggered by 1-O-octadecyl-2-O-methyl-rac-glycero-3-phospho choline is prevented by increased expression of CTP: phospho choline cytidylyl transferase. J. Biol. Chem. 1998;273:2169-73.
  21. Амчеславский В.Г., Генералов В.О., Амчеславская Е.В. Черепно-мозговая травма. Методическое пособие. М.: МАИ-Принт, 201 1. 48 с.
  22. D'Orlando K.J., Sandage B.W. Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury. Neurol. Res. 1995;17:281-4.
  23. Murray G.D., Teasdale G.M., Braakman R., Braakman R., Cohadon F., Dearden M., lannotti F., Karimi A., Lapierre F., Maas A., Ohman J., Persson L., Servadei F., Stocchetti N., Trojanowski T., Unterberg A. The European brain injury consortium survey of head injuries. Acta. Neurochir. (Wien). 1999;141:223-36.
  24. Adibhatla R.M., Hatcher J.F., Dempsey R.J. Citicoline: neuroprotective mechanisms in cerebral ischemia. J. Neurochem. 2002;80:12-23.
  25. Lozano R. CDP-choline in the treatment of cranio-encephalic traumata. J. Neurol Sci. 1991;103 Suppl:43-7.
  26. Calatayud M.V., Calatayud P., Aso E.J. Effects of CDP-choline on the recovery of patients with head injury. J. Neurol Sci. 1991;103 Suppl:15-8.
  27. Tanovich A., Alfaro V., Secades J.J. Citicoline in treatment of traumatic brain damage. Drugs of Today. 2004;40 (Suppl B):1-18.
  28. Zafonte R., Friedewald W.T., Lee S.M., Levin B., Diaz-Arrastia R., Ansel B., Eisenberg H., Timmons S.D., Temkin N., Novack T., Ricker J., Merchant R., Jallo J. The Citicoline Brain Injury Treatment (COBRIT) Trial: design and methods. J. Neurotrauma. 2009;26(12):2207-16.
  29. Adibhatla R.M. Citicoline in stroke and TBI clinical trials. Nat. Rev. Neurol. 2013;9(3):173.
  30. Secades J.J. Citicoline for the treatment of head injury: a systematic review and meta-analysis of controlled clinical trials. J. Trauma Treat. 2014;4(1):2-4.
  31. Khan F., Baguley I.J., Cameron I.D. Rehabilitation after traumatic brain injury. Med. J. Aust. 2003;178(6):290-5.
  32. Sobrado M., Lopez M.G., Carceller F., Garcia A.G., Roda J.M. Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase Bcl-2 expression after focal cerebral ischemia. Neuroscience. 2003;118:107-13.
  33. Maejima S., Katayama Y. Neurosurgical trauma in Japan. World J. Surg. 2014;25(9):1205-9.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies